Response to the letter by Dr. Demetrios Moris "Reply to Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel".
Department of Neurology, Jinling Hospital, Second Military Medical University, Nanjing, China; Department of Geriatric Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Yingting
Y
Wang
Department of Neurology, Jinling Hospital, Southern Medical University, Nanjing, China.
Huan
H
Cai
Department of Geriatric Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Guoqing
G
Zhou
Department of Neurology, Jinling Hospital, Second Military Medical University, Nanjing, China.
Zhizhong
Z
Zhang
Department of Neurology, Jinling Hospital, Second Military Medical University, Nanjing, China. Electronic address: xfliu2@vip.163.com.
Xinfeng
X
Liu
D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19 / Q000235:genetics*; D005838:Genotype; D006801:Humans; D010975:Platelet Aggregation Inhibitors; D011110:Polymorphism, Genetic; D020521:Stroke; D013988:Ticlopidine / Q000031:analogs & derivatives
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine
CYP2C19; Clopidogrel; Genetic variants